This inventor holds 7 USPTO granted patents. Top assignees: Labsystems Oy, Kommandiittiyhtio Finnpipette Osmo a. Suovaniemi, Locus Genex Oy. Active years: 1982-1995.
Company Filing History:

Years Active: 1982-1995
As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll create an article about inventor Paul Partanen based on the provided data.
Title: Unveiling the Innovations of Paul Partanen: Pioneering Inventor from Helsinki
Introduction:
Paul Partanen, a prolific inventor hailing from Helsinki, Finland, has left a significant mark in the field of medical diagnostics and laboratory equipment. With seven patents to his name, Paul's inventive spirit has revolutionized the way reactive conditions are detected and immunological assays are conducted.
Latest Patents:
1. Method for the detection of reactive conditions: Paul's groundbreaking invention focuses on diagnosing reactive conditions, particularly malignant tumors, by measuring the amount of cellular fibronectin in body fluids. The elevated levels of fibronectin serve as a marker for various reactive conditions, including colon carcinoma.
2. Combined incubator and cuvette holding apparatus: This patent showcases Paul's innovative approach to immunological assay systems, where cuvettes' inner surfaces act as the solid phase for assays. The equipment automates all operations, featuring a displaceable carriage for cuvettes and a dosage head for liquid dosing and measurements.
Career Highlights:
Paul Partanen has lent his inventive expertise to renowned companies such as Labsystems Oy and Finnpipette Osmo A. Suovaniemi. His contributions have played a pivotal role in advancing the capabilities of diagnostic technologies and laboratory instrumentation.
Collaborations:
Throughout his career, Paul has collaborated closely with industry stalwarts like Osmo A. Suovaniemi and Pertti Ekholm, pooling their collective knowledge and experience to drive innovation in the medical diagnostics and laboratory equipment sector.
Conclusion:
In conclusion, Paul Partanen stands as a testament to the power of innovation and ingenuity in transforming healthcare and laboratory practices. His patents continue to shape the landscape of diagnostic methodologies, paving the way for more accurate and efficient detection of various reactive conditions. Paul's legacy as an inventor par excellence is etched in the annals of medical technology, inspiring future generations to push the boundaries of scientific discovery.